Althea Group Holdings Ltd
ASX:AGH

Watchlist Manager
Althea Group Holdings Ltd Logo
Althea Group Holdings Ltd
ASX:AGH
Watchlist
Price: 0.02 AUD
Market Cap: 16.9m AUD

Profitability Summary

Althea Group Holdings Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Althea Group Holdings Ltd

Revenue
25.6m AUD
Cost of Revenue
-10.2m AUD
Gross Profit
15.4m AUD
Operating Expenses
-22.9m AUD
Operating Income
-7.5m AUD
Other Expenses
-9.5m AUD
Net Income
-17m AUD

Margins Comparison
Althea Group Holdings Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
AU
Althea Group Holdings Ltd
ASX:AGH
16.9m AUD
60%
-29%
-66%
US
Eli Lilly and Co
NYSE:LLY
717.8B USD
83%
42%
26%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
3%
-4%
US
Johnson & Johnson
NYSE:JNJ
420.9B USD
68%
26%
25%
CH
Roche Holding AG
SIX:ROG
214.8B CHF
74%
33%
14%
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
84%
46%
36%
UK
AstraZeneca PLC
LSE:AZN
178.3B GBP
82%
24%
15%
CH
Novartis AG
SIX:NOVN
190B CHF
76%
33%
25%
US
Merck & Co Inc
NYSE:MRK
203.1B USD
78%
38%
26%
IE
Endo International PLC
LSE:0Y5F
197.4B USD
68%
11%
-126%
US
Pfizer Inc
NYSE:PFE
138.1B USD
74%
29%
17%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Althea Group Holdings Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
AU
Althea Group Holdings Ltd
ASX:AGH
16.9m AUD
-218%
-54%
-52%
-36%
US
Eli Lilly and Co
NYSE:LLY
717.8B USD
87%
16%
42%
23%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
-2%
2%
2%
US
Johnson & Johnson
NYSE:JNJ
420.9B USD
31%
12%
18%
14%
CH
Roche Holding AG
SIX:ROG
214.8B CHF
27%
9%
29%
20%
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
79%
26%
63%
32%
UK
AstraZeneca PLC
LSE:AZN
178.3B GBP
20%
8%
18%
14%
CH
Novartis AG
SIX:NOVN
190B CHF
33%
14%
26%
18%
US
Merck & Co Inc
NYSE:MRK
203.1B USD
36%
14%
27%
20%
IE
Endo International PLC
LSE:0Y5F
197.4B USD
70%
-51%
5%
6%
US
Pfizer Inc
NYSE:PFE
138.1B USD
12%
5%
10%
10%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less